175 Astrocyte and Oligodendrocyte Crosstalk microglia triggers neurotoxicity. Nat Neurosci. Jul 2001;4(7):702-10. doi:10.1038/89490 141. Jeremic A, et al. ATP stimulates calcium-dependent glutamate release from cultured astrocytes. J Neurochem. Apr 2001;77(2):664-75. doi:10.1046/ j.1471-4159.2001.00272.x 142.Wang X, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med. Aug 2004;10(8):821-7. doi:10.1038/nm1082 143. Amadio S, et al. Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. Front Immunol. 2017;8:1529. doi:10.3389/fimmu.2017.01529 144. Beamer E, et al. The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy. Front Neurosci. 2017/02/02 2017;11:21. doi:10.3389/fnins.2017.00021 145.Olsen JA, et al. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. J Neurosci Res. May 2015;93(5):68796. doi:10.1002/jnr.23493 146. Van Strien ME, et al. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells intomyelin-forming oligodendrocytes during CNS remyelination. Glia. Nov 2011;59(11):1622-34. doi:10.1002/glia.21204 147. Franklin RJM, et al. Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci. Nov 16 2017;18(12):753-769. doi:10.1038/nrn.2017.136 148. Albrecht PJ, et al. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol Dis. Jul 2003;13(2):89-101. doi:10.1016/ s0969-9961(03)00019-6 149. Yeung MSY, et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature. Feb 2019;566(7745):538-542. doi:10.1038/s41586018-0842-3 150. Lau LW, et al. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. Oct 2013;14(10):722-9. doi:10.1038/nrn3550 151.Mohassel P, et al. Extracellular matrix-driven congenital muscular dystrophies. Matrix Biol. Oct 2018;71-72:188-204. doi:10.1016/j. matbio.2018.06.005 152. van Horssen J, et al. The extracellular matrix in multiple sclerosis pathology. J Neurochem. Nov 2007;103(4):1293-301. doi:10.1111/j.14714159.2007.04897.x 153. Lau LW, et al. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann Neurol. Sep 2012;72(3):419-32. doi:10.1002/ ana.23599 154. Jiang P, et al. Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion. Cell Rep. May 10 2016;15(6):1303-15. doi:10.1016/j. celrep.2016.04.011 155.Miyamoto N, et al. Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor. J Neurosci. Oct 14 2015;35(41):14002-8. doi:10.1523/ JNEUROSCI.1592-15.2015 156.Wang P, et al. MMP7 cleaves remyelinationimpairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions. Glia. Aug 2018;66(8):1625-1643. doi:10.1002/ glia.23328
RkJQdWJsaXNoZXIy MTk4NDMw